Skip to main content
Home
B-Cell Lymphoma ICYMI
    • FULL MENUFULL MENU Presented by
    • MDedge
    Home
    • Clinical Edge Journal Scan
    • Clinical Topics
    • Conference Coverage
    • Expert Perspectives
    • MD-IQ

    Clinical Topics

    August 29, 2022

    ‘Molecular map’ of CLL yields fresh genetic insights

    August 29, 2022
    Randy Dotinga
    Randy Dotinga
    August 29, 2022
    B-Cell Lymphoma ICYMI
    August 2, 2022

    Many die waiting for `last-chance’ therapy

    August 2, 2022
    Roxanne Nelson, RN, BSN
    Roxanne Nelson, RN, BSN
    August 2, 2022
    ASCO: American Society of Clinical Oncology
    B-Cell Lymphoma ICYMI
    July 18, 2022

    Drug shortages plague hematology, but preparedness helps

    July 18, 2022
    Randy Dotinga
    Randy Dotinga
    July 18, 2022
    B-Cell Lymphoma ICYMI
    June 27, 2022

    FDA approves liso-cel as second-line therapy for LBCL

    June 27, 2022
    Sharon Worcester
    Sharon Worcester
    June 27, 2022
    B-Cell Lymphoma ICYMI
    February 3, 2022

    EMA gives green light to new CAR T-cell therapy

    February 3, 2022
    Roxanne Nelson, RN
    Roxanne Nelson, RN
    February 3, 2022
    B-Cell Lymphoma ICYMI
    January 21, 2022

    100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'

    January 21, 2022
    Helen Leask, PhD
    Helen Leask, PhD
    January 21, 2022
    B-Cell Lymphoma ICYMI
    November 8, 2021

    Decades spent searching for genes linked to rare blood cancer

    November 8, 2021
    Pam Harrison
    Pam Harrison
    November 8, 2021
    B-Cell Lymphoma ICYMI
    September 20, 2021

    Transfusions, readmissions higher for patients with CLL after cardiac surgery

    September 20, 2021
    Mark S. Lesney, PhD
    Mark S. Lesney, PhD
    September 20, 2021
    B-Cell Lymphoma ICYMI
    Read More

    Conference Coverage

    June 16, 2023

    CLL: Venetoclax-obinutuzumab combo effective long term

    June 16, 2023
    Liam Davenport
    Liam Davenport
    June 16, 2023
    EHA: European Hematology Association
    B-Cell Lymphoma ICYMI
    June 8, 2023

    `Remarkable’: CAR T therapy for CLL/SLL

    June 8, 2023
    Nancy A. Melville
    Nancy A. Melville
    June 8, 2023
    ASCO: American Society of Clinical Oncology
    B-Cell Lymphoma ICYMI
    June 6, 2023

    PMBCL: Postremission, patients may safely skip radiation

    June 6, 2023
    Nancy A. Melville
    Nancy A. Melville
    June 6, 2023
    ASCO: American Society of Clinical Oncology
    B-Cell Lymphoma ICYMI
    April 24, 2023

    Frontline CLL treatment: Avoiding adverse events

    April 24, 2023
    Myles Starr
    Myles Starr
    April 24, 2023
    B-Cell Lymphoma ICYMI
    February 21, 2023

    CML: Preventing chemo-induced vascular toxicity

    February 21, 2023
    Vincent Richeux
    Vincent Richeux
    February 21, 2023
    B-Cell Lymphoma ICYMI
    December 16, 2022

    CLL phase 3 study: Zanubrutinib bests ibrutinib

    December 16, 2022
    Andrew D. Bowser
    Andrew D. Bowser
    December 16, 2022
    ASH: American Society of Hematology
    B-Cell Lymphoma ICYMI
    December 12, 2022

    MCL: Ibrutinib could become the ‘new standard’

    December 12, 2022
    Randy Dotinga
    Randy Dotinga
    December 12, 2022
    ASH: American Society of Hematology
    B-Cell Lymphoma ICYMI
    December 7, 2022

    ASH 2022: New clinical data challenge long-held assumptions

    December 7, 2022
    Neil Osterweil
    Neil Osterweil
    December 7, 2022
    ASH: American Society of Hematology
    B-Cell Lymphoma ICYMI
    Read More

    Expert Perspective

    May 22, 2023

    Emerging Treatment Options for Mantle Cell Lymphoma

    May 22, 2023
    Julie M. Vose, MD, MBA
    Julie M. Vose, MD, MBA
    May 22, 2023
    B-Cell Lymphoma ICYMI
    March 1, 2023

    The Evolving Role for Transplantation in Mantle Cell Lymphoma

    March 1, 2023
    Michael E. Williams, MD, ScM
    Michael E. Williams, MD, ScM
    March 1, 2023
    B-Cell Lymphoma ICYMI
    Read More

    MD-IQ

    B-Cell Lymphoma Subtypes

    More

    Clinical Edge Journal Scan

    July 22, 2023

    Bruton tyrosine kinase inhibitors improve outcomes in CLL when combined with anti-CD20 mAb

    July 22, 2023
    July 22, 2023
    B-Cell Lymphoma ICYMI
    July 22, 2023

    A lymph node diameter > 56.5 mm strongly predicts progression during venetoclax treatment in CLL

    July 22, 2023
    July 22, 2023
    B-Cell Lymphoma ICYMI
    July 22, 2023

    Soluble CD163 holds prognostic value in chemoimmunotherapy- and targeted therapy-treated MCL

    July 22, 2023
    July 22, 2023
    B-Cell Lymphoma ICYMI
    July 22, 2023

    First-line ibrutinib an effective treatment for patients with CLL carrying TP53 aberrations

    July 22, 2023
    July 22, 2023
    B-Cell Lymphoma ICYMI
    Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    FULL MENU FULL MENU Presented by
    • FULL MENU FULL MENU
      • Clinical Edge Journal Scan
      • Clinical Topics
      • Conference Coverage
      • Expert Perspectives
      • MD-IQ

      More

      • MDedge
    • Clinical Edge Journal Scan
    • Clinical Topics
    • Conference Coverage
    • Expert Perspectives
    • MD-IQ

    More

    • MDedge